Universitäts-Kinderspital beider Basel (UKBB)
Welcome,         Profile    Billing    Logout  
 21 Trials 
37 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gaab, Jens
OLP-POP, NCT04339023: Open-Label Placebo Treatment for Acute Postoperative Pain

Completed
N/A
76
Europe
Open-Label Placebo, treatment as usual
University Hospital, Basel, Switzerland
Postoperative Pain
01/23
01/23
NCT04130126: Feasibility and Effects of Taking Cold Showers: A Randomized Controlled Study

Completed
N/A
350
Europe
Taking cold showers
University Hospital, Basel, Switzerland
Sick Leave
03/23
12/23
MICS, NCT05497713: Mindset Interventions to Facilitate Taking Cold Showers

Active, not recruiting
N/A
476
Europe
Mindsets
Jens Gaab
Psychological
02/24
12/24
BOLPAP, NCT05819476: Boosting Open-Label Placebo Effects in Acute Induced Pain in Healthy Adults

Recruiting
N/A
141
Europe
OLP-injection, Scripted Evidence-based treatment rationale, Experimental model of acute pain
University Hospital, Basel, Switzerland
Acute Pain
04/24
04/24
Khanna, Nina
NCT04836260: Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19

Recruiting
3
100
Europe
SARS-CoV-2 convalescent plasma
University Hospital, Geneva, University Hospital, Basel, Switzerland, Ospedale Regionale di Lugano, Hôpital Fribourgeois
Covid19, Immuno-Deficiency, Old Age; Debility
12/21
12/21
NCT02007356: A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

Recruiting
2
30
Europe
IFN-γ positive selected T-cells
University Hospital, Basel, Switzerland
Adenovirus Infection, EBV, Cytomegalovirus Infections, Cytokine Capture System, Allogenic Disease
12/26
12/26
OPTICOV, NCT05587894: OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial

Recruiting
2
256
Europe
Paxlovid 5 days, Nirmatrevlir/ritonavir, Paxlovid 10 days, Veklury, remdesivir
ANRS, Emerging Infectious Diseases, University Hospital, Geneva
COVID-19, Immunodeficiency
03/25
05/25
ESPECT, NCT05688241: EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Not yet recruiting
1/2
10
Europe
Donor-derived ex-vivo expanded EBV Tscm CTL
University Hospital, Basel, Switzerland
EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD)
12/25
12/25
BIMI, NCT04720144: Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis

Recruiting
N/A
300
Europe
Centre Hospitalier Universitaire Vaudois
Invasive Mold Infections, Breakthrough Invasive Mold Infections, Hematologic Malignancy, Hematologic Diseases
09/22
09/22
PTX3 AML, NCT03828773: PTX3-targeted Antifungal Prophylaxis

Recruiting
N/A
320
Europe
Posaconazole, Noxafil, Fluconazole, Diflucan
Bochud Pierre-Yves, Swiss National Science Foundation
Candidiasis, Fungal Infection, Acute Myeloid Leukemia, Genetic Predisposition, Aspergillosis
11/25
11/25
AntiResist, NCT05017766: NCCR : New Approaches to Combat Antibiotic-resistant Bacteria

Recruiting
N/A
8000
Europe
analysis of antimicrobial resistance
University Hospital, Basel, Switzerland, Swiss National Science Foundation
Antimicrobial Resistance (AMR)
12/24
12/24
Weid, Nicolas X von der
NCT02670564: ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Recruiting
4
1000
Europe
Pharmacogenomics, DNA analyses, Busulfan plasma level measurements
Swiss Pediatric Oncology Group, ALL SCTped Forum
Acute Lymphoblastic Leukemia
04/21
04/26
HR-NBL2, NCT04221035 / 2019-001068-31: High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Recruiting
3
800
Europe, RoW
Vincristine, L01CA02, Carboplatin, LO1XA02, Etoposide, L01CB01, Vindesine, L01CA03, Dacarbazine, L01AX04, Ifosfamide, Doxorubicin, L01DB01, Busulfan, L01AB01, Melphalan, L01AA03, Thiotepa, L01AC01, Radiotherapy, Dinutuximab Beta, L01XC16, Cisplatin, L01XA01, Temozolomide 100 MG, Irinotecan, Cyclophosphamid
Gustave Roussy, Cancer Campus, Grand Paris, PHRC, Solving Kids' Cancer Europe, Neuroblastoma UK, , BSPHO, Instituto de Investigación Sanitaria La Fe, Deutsche Krebshilfe
High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
11/26
11/32
AIEOP-BFM ALL 2017, NCT03643276 / 2016-001935-12: Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia -

Recruiting
3
5000
Europe, RoW
Blinatumomab, Bortezomib, Cyclophosphamide, Cytarabine, Daunorubicin, Myocet, Dexamethasone, Doxorubicin, Etoposide, Fludarabine Phosphate, Ifosfamide, 6-Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Tioguanin, Vincristine, Vindesine, Erwinase
Martin Schrappe, Deutsche Krebshilfe e.V., Bonn (Germany)
Acute Lymphoblastic Leukemia, Pediatric
07/28
07/28
FORUM, NCT01949129 / 2012-003032-22: Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Recruiting
2/3
1800
Europe, Canada, RoW
VP16, Etoposide, TBI, Thiotepa, Thio, Treosulfan, Treo, Fludarabine, Flu, Busulfan, Bu, ATG Thymoglobulin, ATG Thymo, Cyclophosphamide, Cy, Grafalon, Anti-human T-lymphocyte immunoglobulin
St. Anna Kinderkrebsforschung, ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group
Acute Lymphoblastic Leukaemia
06/25
04/30
Kid-MaCareOnco, NCT04308642: Study to Evaluate Blood and Urine Kidney Injury Markers to Facilitate Early Detection of Renal Adverse Drug Events in Pediatric Cancer Patients Treated With Nephrotoxic Chemotherapy

Completed
N/A
6
Europe
blood test for renal biomarkers, urine test for renal biomarkers
University Hospital, Basel, Switzerland, Stiftung für Krebskranke Kinder
Kidney Impairment
12/23
12/23
Cardio-Onco, NCT03790943: Cardiac Dysfunction in Childhood Cancer Survivors

Recruiting
N/A
500
Europe
cardiac assessment
University of Bern, University Hospital, Basel, Switzerland, University Children's Hospital Basel, Insel Gruppe AG, University Hospital Bern, Cantonal Hospital of St. Gallen, Luzerner Kantonsspital, University Hospital, Geneva
Cardiac Dysfunction, Cardiovascular Diseases, Childhood Cancer
12/23
01/24
PrepAIR, NCT05606588: Preventing Sensory and Motor Dysfunctions in Children Receiving Neurotoxic Chemotherapy

Recruiting
N/A
131
Europe
Playful sensorimotor training
University of Basel, University Hospital Inselspital, Berne, Kantonsspital Aarau, Ostschweizer Kinderspital, University Hospital Heidelberg, University Hospital Freiburg, Krebsforschung Schweiz, Bern, Switzerland, Clinical Trial Unit, University Hospital Basel, Switzerland, Charite University, Berlin, Germany, National Center for Tumor Diseases, Heidelberg
Chemotherapy-induced Peripheral Neuropathy, Pediatric Cancer
03/25
03/26
NCT02512250: Swiss Hemophilia Registry

Recruiting
N/A
900
Europe
Registry
Swiss Hemophilia Network
Hemophilia and Other Severe Bleeding Disorders
12/25
12/25
SCCSS-FU, NCT04732273: The Swiss Childhood Cancer Survivor Study - Follow-up (SCCSS-FollowUp)

Recruiting
N/A
3000
Europe
Physical examination, diagnostic tests, laboratory tests, Personal history, questionnaire
University of Bern
Late Effect, Childhood Cancer
01/71
01/71
SWISS-Pearl, NCT05427136: Early Pulmonary Dysfunction in Childhood Cancer Patients

Recruiting
N/A
140
Europe
Lung function measurements, Breath Analysis, Magnetic resonance imaging (MRI), Standardized interview to assess respiratory symptoms, Data collection for assessment of clinical parameters and cumulative doses to chemotherapy, radiation, surgery and HSCT, Collection of genetic samples
University Children's Hospital Basel
Pulmonary Dysfunction
06/51
06/51
Diesch, Tamara
ACCS, NCT04284189: Aftercare of Childhood Cancer Survivors in Switzerland

Recruiting
N/A
140
Europe
Transition model
Kantonsspital Aarau, University Children's Hospital Basel, Luzerner Kantonsspital
Childhood Cancer, Survivorship, Transition
04/25
08/30
Furlano, Raoul
NCT03146884: Swiss Autoimmune Hepatitis Cohort Study

Recruiting
N/A
500
Europe
Fondazione Epatocentro Ticino
Hepatitis, Autoimmune
12/22
12/22
NCT03146936: Swiss Primary Sclerosing Cholangitis Cohort Study

Recruiting
N/A
120
Europe
Fondazione Epatocentro Ticino
Cholangitis, Sclerosing
12/22
12/22
NCT04714021: CO2 vs Air Insufflation in Children Undergoing PEG

Recruiting
N/A
120
Europe, RoW
CO2, air
University Medical Centre Ljubljana, European Society of Pediatric Gastroenterology, Hepatology and Nutrition
Gastrostomy
01/23
01/23
BOUGIE-PED, NCT06675825: An Innovative Endoscopic Cap for Dilating Benign Esophageal Strictures in Children

Recruiting
N/A
40
Europe
BougieCap, Esophageal dilation, Savary-Bougie (A) or balloon dilation (B), Dilation of esophageal stricture
University Children's Hospital, Zurich
Esophageal Stenosis, Esophageal Dilation
12/26
12/26
Paccou, Emmanuelle
Lutre-UP, NCT04390646: GnRH Therapy on Cognition in Down Syndrome

Recruiting
2/3
56
Europe
GnRH, gonadorelin acetate, Lutrelef, 0.9% NaCl
Nelly Pitteloud
Down Syndrome, Cognitive Decline, Alzheimer Disease, Early Onset, Olfaction Disorders
12/28
12/28
NCT01601171: Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate

Recruiting
N/A
2000
Europe
Centre Hospitalier Universitaire Vaudois, Swiss National Science Foundation
Kallmann Syndrome, Hypogonadotropic Hypogonadism, Hypothalamic Amenorrhea, Polycystic Ovarian Syndrome, Precocious Puberty, Cleft Lip and Palate, Cleft Palate, Cleft Lip
03/25
03/30
MiniNO, NCT05058781: Minipuberty in Infants Born With Potential Hypogonadism Hypogonadotrope

Recruiting
N/A
100
Europe
Centre Hospitalier Universitaire Vaudois
DSD, CHH
12/26
12/30
Sinues, Pablo
EBECA, NCT04461821: Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents

Recruiting
N/A
3600
Europe
Real-time SESI-MS breath analysis, Off-line breath analysis, Blood analysis, Saliva analysis, Urine analysis
University Children's Hospital Basel, Swiss National Science Foundation, Fondation Botnar (Switzerland)
Respiratory Diseases, Neurological Disorders, Type 1 Diabetes
07/30
07/30
Chybicka, Alicja
FORUM, NCT01949129 / 2012-003032-22: Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Recruiting
2/3
1800
Europe, Canada, RoW
VP16, Etoposide, TBI, Thiotepa, Thio, Treosulfan, Treo, Fludarabine, Flu, Busulfan, Bu, ATG Thymoglobulin, ATG Thymo, Cyclophosphamide, Cy, Grafalon, Anti-human T-lymphocyte immunoglobulin
St. Anna Kinderkrebsforschung, ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group
Acute Lymphoblastic Leukaemia
06/25
04/30
Richard, Mélina D
EBECA, NCT04461821: Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents

Recruiting
N/A
3600
Europe
Real-time SESI-MS breath analysis, Off-line breath analysis, Blood analysis, Saliva analysis, Urine analysis
University Children's Hospital Basel, Swiss National Science Foundation, Fondation Botnar (Switzerland)
Respiratory Diseases, Neurological Disorders, Type 1 Diabetes
07/30
07/30
Benninger, Sabina Kroiss
HR-NBL2, NCT04221035 / 2019-001068-31: High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Recruiting
3
800
Europe, RoW
Vincristine, L01CA02, Carboplatin, LO1XA02, Etoposide, L01CB01, Vindesine, L01CA03, Dacarbazine, L01AX04, Ifosfamide, Doxorubicin, L01DB01, Busulfan, L01AB01, Melphalan, L01AA03, Thiotepa, L01AC01, Radiotherapy, Dinutuximab Beta, L01XC16, Cisplatin, L01XA01, Temozolomide 100 MG, Irinotecan, Cyclophosphamid
Gustave Roussy, Cancer Campus, Grand Paris, PHRC, Solving Kids' Cancer Europe, Neuroblastoma UK, , BSPHO, Instituto de Investigación Sanitaria La Fe, Deutsche Krebshilfe
High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
11/26
11/32
Krieg, Andreas
TANGENT, NCT05417789: Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

Recruiting
3
128
Europe, Canada, US, RoW
Emactuzumab, Placebo
SynOx Therapeutics Limited
TGCT
04/26
09/27
MOTION, NCT05059262 / 2020-004883-25: Study of Vimseltinib for Tenosynovial Giant Cell Tumor

Active, not recruiting
3
120
Europe, Canada, US, RoW
vimseltinib, DCC-3014, Placebo
Deciphera Pharmaceuticals LLC, Deciphera Pharmaceuticals, LLC
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Diffuse, Tenosynovial Giant Cell Tumor, Localized
08/23
07/26
Furlanetto, Tamara Diesch-
ESPECT, NCT05688241: EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Not yet recruiting
1/2
10
Europe
Donor-derived ex-vivo expanded EBV Tscm CTL
University Hospital, Basel, Switzerland
EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD)
12/25
12/25
Widmer, Michèle
NCT06648408: Ballet Training in Children With Idiopathic Coxa Antetorta

Recruiting
N/A
17
Europe
Balett Training
University Children's Hospital Basel
Femoral Anteversion
04/25
04/25

Download Options